Skip to main content
OpenTrials

Clinical trial condition

Desmoplastic Small Round Cell Tumor

Explore clinical trials studying Desmoplastic Small Round Cell Tumor. Study availability and eligibility vary by location and protocol.

20 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Desmoplastic Small Round Cell Tumor trial results

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 28 locations
View Trial Details
Recruiting

Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS

NCT07328425

Conditions
Desmoplastic Small Round Cell Tumor, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • Fondazione del Piemonte per l'Oncologia IRCCS Candiolo, Torino, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • IOV Istituto Oncologico Veneto IRCCS Padova, Italy
  • Nuovo Ospedale "S.Stefano" Prato, Italy
View Trial Details
Recruiting

Lurbinectedin in FET-Fused Tumors

NCT05918640

Conditions
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, Neoplasms, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

NCT06709495

Conditions
Desmoplastic Small Round Cell Tumor, Myosarcoma, Neoplasms, +10 more
Locations
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

NCT03967834

Conditions
Alveolar Soft Part Sarcoma, Clear Cell Sarcoma, Desmoplastic Small Round Cell Tumor, +19 more
Locations
  • Chu Besancon - Site Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View all 20 locations
View Trial Details

Related conditions